Form 4: Merit Medical Systems COO Neil Peterson Reports Stock Transactions

Neil Peterson, COO of Merit Medical Systems, reports acquisition and disposal of common stock and grants of restricted stock units.

Summary

• Neil Peterson, the Chief Operating Officer of Merit Medical Systems, filed a Form 4 detailing changes in beneficial ownership.
• On February 27, 2025, Peterson acquired 11,533 shares of common stock at $0, and disposed of 4,255 shares at $98.5 for payroll taxes.
• On February 28, 2025, Peterson acquired 6,272 restricted stock units (RSUs) at $0.
• Following these transactions, Peterson directly owns 28,369 shares of common stock.
• Peterson also holds non-qualified stock options to purchase 15,000 shares at $54.4, 25,000 shares at $68.33, and 13,576 shares at $70.58.
• The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The transactions are routine, and the equity grants suggest confidence in the company's future performance. The disposal of shares for tax purposes is a minor negative.

Positives

• The acquisition of shares through performance stock units suggests the company met certain performance goals.
• The grant of restricted stock units incentivizes the COO to remain with the company and contribute to its long-term success.

Negatives

• The disposal of shares to cover payroll taxes, while routine, slightly reduces the COO's holdings in the company.

Future Outlook

The vesting schedule of the restricted stock units indicates continued service and alignment with the company's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates the COO's continued investment in the company through stock ownership and option holdings.

Comparison to Industry Standards

• Stock option and RSU grants are common compensation practices in the medical device industry, aligning executive incentives with shareholder value.
• Companies like Medtronic, Boston Scientific, and Abbott also utilize similar equity-based compensation plans for their executives.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding the COO's stake in the company.
• The equity-based compensation aligns the COO's interests with those of the shareholders.

Key Dates